osteogenesis imperfecta type 15
ORPHA: 2168121 Treatment Available
Overview
osteogenesis imperfecta that has material basis in mutation in the WNT1 gene on chromosome 12q13
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Denosumab Cold Chain | Subcutaneous injection, 120mg/1.7mL solution | FDA Approved | 7 | 14d |
Classification & Codes
Orphanet Code
ORPHA:216812osteogenesis imperfecta type 15
| Orphanet | ORPHA:216812 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO